Navigation Links
Zynerba Pharmaceuticals to Present at Piper Jaffray 26th Annual Healthcare Conference 2014
Date:11/26/2014

RADNOR, Pa., Nov. 26, 2014 /PRNewswire/ -- Zynerba Pharmaceuticals, Inc., a specialty pharmaceutical company dedicated to the development of innovative transdermal synthetic cannabinoid treatments, today announced that the company will present at the Piper Jaffray 26th Annual Healthcare Conference 2014. The conference will be held December 2 to 3, 2014,at the New York Palace in New York. Zynerba's Chairman and CEO, Armando Anido, will present at 4:50 pm on Tuesday, December 2.

To listen to a webcast of this presentation during the event, please visit the Investor Relations page of www.zynerba.com.

About Zynerba Pharmaceuticals

Zynerba Pharmaceuticals is dedicated to the development of innovative transdermal synthetic cannabinoid treatments for patients with high unmet medical needs using modern drug delivery technology and appropriate regulatory pathways. Zynerba is developing two therapeutic candidates based on proprietary transdermal technologies that, if successfully developed, may allow sustained, consistent and controlled delivery of therapeutic levels of cannabinoids. Transdermal delivery reduces adverse effects associated with oral dosing. ZYN001 will be studied in chronic cancer pain, fibromyalgia, and peripheral neuropathic pain utilizing a synthetically manufactured prodrug of THC in a transdermal patch to deliver THC through the skin and into the bloodstream. Zynerba expects to initiate ZYN001 Phase 1 clinical studies in 3Q 2015. ZYN002 will be studied in refractory epilepsy and arthritis, utilizing a proprietary gel to deliver synthetically manufactured cannabidiol (CBD), a non-psychotropic cannabinoid, through the skin and into the bloodstream. Zynerba expects to initiate ZYN002 Phase 1 clinical studies in 3Q 2015. Learn more at www.zynerba.com and follow the company on Twitter at @ZynerbaPharma.


'/>"/>
SOURCE Zynerba Pharmaceuticals, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Zynerba Pharmaceuticals Raises $13 Million to Develop First and Only Transdermal Cannabinoid Therapies
2. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
3. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
4. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
5. BioElectronics Survey Indicates a Five-Fold Superior Pain Relief Compared to OTC Pharmaceuticals
6. Icahn Issues Statement Regarding Amylin Pharmaceuticals
7. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
8. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
9. Onyx Pharmaceuticals Announces FDA Advisory Committee to Review Carfilzomib for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma
10. Jazz Pharmaceuticals Announces First Quarter 2012 Financial Results Conference Call On May 8, 2012
11. Inovio Pharmaceuticals Granted U.S. Patent Protection for Synthetic Vaccine for Cervical Dysplasia and Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2018)... ... December 14, 2018 , ... When it comes to ... often the case for alleviating the chronic, gnawing pain caused by degenerating or damaged ... , As a minimally-invasive, conservative option for bringing his patients relief, Dr. ...
(Date:12/14/2018)... CHICAGO (PRWEB) , ... December 14, 2018 , ... ... gratitude to our corporate partners sponsoring the Becker's Hospital Review 10th Annual Meeting ... than 300 hospital and health system executive speakers comprise a full agenda of ...
(Date:12/13/2018)... ... 2018 , ... Dr. Cory M. Lessner, Laser vision correction ... The Haute Beauty Network, well known for their exclusivity, and luxurious lifestyle publication ... newest addition to the Haute Living partnership. , Haute Beauty offers a ...
Breaking Medicine Technology:
(Date:12/14/2018)... ... 14, 2018 , ... Becker's Hospital Review is pleased to welcome Super Bowl ... artist and Entrepreneur Bobbi Brown; and Founder of KevinMD.com Kevin Pho, MD, as celebrity ... 2 to 4 at the Swissotel in Chicago. The event will include eight keynote ...
(Date:12/13/2018)... MELBOURNE, Fla. (PRWEB) , ... December 13, 2018 , ... ... inducted into the RealSelf Hall of Fame, an honor recognizing the highest-rated and most ... treatments and connect with medical aesthetic providers. Dr. Clevens has been named a “Distinguished ...
(Date:12/13/2018)... ... , ... Shady Grove Fertility (SGF) welcomes reproductive ... patients at SGF’s Woodbridge, VA location. Dr. Swelstad will provide patients ... for female and male infertility, as well as elective fertility preservation, oncofertility care ...
(Date:12/13/2018)... ... December 13, 2018 , ... Researchers at the Icahn School of Medicine ... induces the highest rate of proliferation ever observed in adult human beta cells—the cells ... diabetes treatment that restores the body’s ability to produce insulin. , The finding involved ...
(Date:12/13/2018)... ... 2018 , ... LifeStation today announced the availability of Find My Loved One, a premium feature ... caregivers the ability to locate a loved one at any time. With the ability ... mind for children, relatives, and caregivers. , Here’s how it works: , 1. ...
Breaking Medicine News(10 mins):